CompletedNot Applicable

Improving Screening and Therapy for Hispanic/Latinx at Risk for CKD

United States248 participantsStarted 2023-05-18

Plain-language summary

In Aim 1 of this study, the investigators will utilize community organizations to screen Hispanics/Latino(a)s for kidney disease, diabetes, and other risk factors, and refer them for care with a PCP. In Aim 2, the investigators will implement an intervention in local health clinics to assist PCPs with screening and treating Hispanic and Black patients with diabetes. Completion of the project will hopefully slow progression of kidney disease among Hispanic/Latino(a) and Black patients in Durham, and the information gained will allow the investigators to eventually perform the intervention on a larger scale.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Aim 1: Inclusion Criteria: * Age 18 or older at time of screening * Self-identifying as Hispanic/Latinx ethnicity. Exclusion Criteria: * Unable to be reached by telephone

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Number of Participants Who Attended or Scheduled a Primary Care Physician (PCP) Visit

Timeframe: up to 3 months after screening

Number of Participants Who Received Urine Albumin-to-Creatinine Ratio (uACR) Screening

Timeframe: Within three months of T0 (primary care appointment)

Number of Participants Who Were Prescribed an SGLT2 Inhibitor (SGLT2i) and/or a GLP-1 Receptor Agonist (GLP-1 RA)

Timeframe: Within three months of T0 (primary care appointment)

Number of Participants Who Were Prescribed a Renin-Angiotensin-Aldosterone System Inhibitor (RAASi)

Timeframe: Within three months of T0 (primary care appointment)

Trial details

NCT IDNCT05734989

SponsorDuke University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-04-04

Results submitted2026-04-03

View on ClinicalTrials.gov More Type 2 Diabetes trials

Plain-language summary

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Aim 1: Inclusion Criteria: * Age 18 or older at time of screening * Self-identifying as Hispanic/Latinx ethnicity. Exclusion Criteria: * Unable to be reached by telephone

What they're measuring

Number of Participants Who Attended or Scheduled a Primary Care Physician (PCP) Visit

Timeframe: up to 3 months after screening

Number of Participants Who Received Urine Albumin-to-Creatinine Ratio (uACR) Screening

Timeframe: Within three months of T0 (primary care appointment)

Number of Participants Who Were Prescribed an SGLT2 Inhibitor (SGLT2i) and/or a GLP-1 Receptor Agonist (GLP-1 RA)

Timeframe: Within three months of T0 (primary care appointment)

Number of Participants Who Were Prescribed a Renin-Angiotensin-Aldosterone System Inhibitor (RAASi)

Timeframe: Within three months of T0 (primary care appointment)